Literature DB >> 33754449

Ending TB: the world's oldest pandemic.

Peter S Kim1, Soumya Swaminathan2.   

Abstract

Entities:  

Keywords:  TB; epidemic; mycobacterium tuberculosis; pandemic; tuberculosis

Year:  2021        PMID： 33754449      PMCID： PMC7985566          DOI： 10.1002/jia2.25698

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN： 1758-2652            Impact factor:   5.396


× No keyword cloud information.
  13 in total

1.  High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

Authors:  Susan E Dorman; Payam Nahid; Ekaterina V Kurbatova; Stefan V Goldberg; Lorna Bozeman; William J Burman; Kwok-Chiu Chang; Michael Chen; Mark Cotton; Kelly E Dooley; Melissa Engle; Pei-Jean Feng; Courtney V Fletcher; Phan Ha; Charles M Heilig; John L Johnson; Erica Lessem; Beverly Metchock; Jose M Miro; Nguyen Viet Nhung; April C Pettit; Patrick P J Phillips; Anthony T Podany; Anne E Purfield; Kathleen Robergeau; Wadzanai Samaneka; Nigel A Scott; Erin Sizemore; Andrew Vernon; Marc Weiner; Susan Swindells; Richard E Chaisson
Journal:  Contemp Clin Trials       Date:  2020-01-22       Impact factor: 2.226

2.  Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.

Authors:  Francesca Conradie; Andreas H Diacon; Nosipho Ngubane; Pauline Howell; Daniel Everitt; Angela M Crook; Carl M Mendel; Erica Egizi; Joanna Moreira; Juliano Timm; Timothy D McHugh; Genevieve H Wills; Anna Bateson; Robert Hunt; Christo Van Niekerk; Mengchun Li; Morounfolu Olugbosi; Melvin Spigelman
Journal:  N Engl J Med       Date:  2020-03-05       Impact factor: 91.245

3.  The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

Authors:  Alex Rosenthal; Andrei Gabrielian; Eric Engle; Darrell E Hurt; Sofia Alexandru; Valeriu Crudu; Eugene Sergueev; Valery Kirichenko; Vladzimir Lapitskii; Eduard Snezhko; Vassili Kovalev; Andrei Astrovko; Alena Skrahina; Jessica Taaffe; Michael Harris; Alyssa Long; Kurt Wollenberg; Irada Akhundova; Sharafat Ismayilova; Aliaksandr Skrahin; Elcan Mammadbayov; Hagigat Gadirova; Rafik Abuzarov; Mehriban Seyfaddinova; Zaza Avaliani; Irina Strambu; Dragos Zaharia; Alexandru Muntean; Eugenia Ghita; Miron Bogdan; Roxana Mindru; Victor Spinu; Alexandra Sora; Catalina Ene; Sergo Vashakidze; Natalia Shubladze; Ucha Nanava; Alexander Tuzikov; Michael Tartakovsky
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

4.  Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.

Authors:  Yuan Cao; Heta Parmar; David Alland; Soumitesh Chakravorty; Rajiv L Gaur; Deanna Lieu; Shobana Raghunath; Nova Via; Simone Battaglia; Daniela M Cirillo; Claudia Denkinger; Sophia Georghiou; Robert Kwiatkowski; David Persing
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

5.  Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors:  Timothy R Sterling; M Elsa Villarino; Andrey S Borisov; Nong Shang; Fred Gordin; Erin Bliven-Sizemore; Judith Hackman; Carol Dukes Hamilton; Dick Menzies; Amy Kerrigan; Stephen E Weis; Marc Weiner; Diane Wing; Marcus B Conde; Lorna Bozeman; C Robert Horsburgh; Richard E Chaisson
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

6.  RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration.

Authors:  Carol D Hamilton; Soumya Swaminathan; Devasahayam J Christopher; Jerrold Ellner; Amita Gupta; Timothy R Sterling; Valeria Rolla; Sudha Srinivasan; Muhammad Karyana; Sophia Siddiqui; Sonia K Stoszek; Peter Kim
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

7.  Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

Authors:  Dereck R Tait; Mark Hatherill; Olivier Van Der Meeren; Ann M Ginsberg; Elana Van Brakel; Bruno Salaun; Thomas J Scriba; Elaine J Akite; Helen M Ayles; Anne Bollaerts; Marie-Ange Demoitié; Andreas Diacon; Thomas G Evans; Paul Gillard; Elizabeth Hellström; James C Innes; Maria Lempicki; Mookho Malahleha; Neil Martinson; Doris Mesia Vela; Monde Muyoyeta; Videlis Nduba; Thierry G Pascal; Michele Tameris; Friedrich Thienemann; Robert J Wilkinson; François Roman
Journal:  N Engl J Med       Date:  2019-10-29       Impact factor: 91.245

8.  GenBank.

Authors:  Eric W Sayers; Mark Cavanaugh; Karen Clark; James Ostell; Kim D Pruitt; Ilene Karsch-Mizrachi
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

9.  GISAID: Global initiative on sharing all influenza data - from vision to reality.

Authors:  Yuelong Shu; John McCauley
Journal:  Euro Surveill       Date:  2017-03-30

10.  Prevention of tuberculosis in macaques after intravenous BCG immunization.

Authors:  Mario Roederer; JoAnne L Flynn; Robert A Seder; Patricia A Darrah; Joseph J Zeppa; Pauline Maiello; Joshua A Hackney; Marc H Wadsworth; Travis K Hughes; Supriya Pokkali; Phillip A Swanson; Nicole L Grant; Mark A Rodgers; Megha Kamath; Chelsea M Causgrove; Dominick J Laddy; Aurelio Bonavia; Danilo Casimiro; Philana Ling Lin; Edwin Klein; Alexander G White; Charles A Scanga; Alex K Shalek
Journal:  Nature       Date:  2020-01-01       Impact factor: 49.962
View more
  2 in total

1.  Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Authors: 
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795

2.  Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice.

Authors:  Ying Waeckerle-Men; Zuzanna K Kotkowska; Géraldine Bono; Agathe Duda; Isabel Kolm; Eleni M Varypataki; Beat Amstutz; Michael Meuli; Anders Høgset; Thomas M Kündig; Cornelia Halin; Peter Sander; Pål Johansen
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.